Implications of HBsAg, HBcAg and HDAg Immunohistochemistry in Course and Treatment of Chronic Delta Hepatitis (CDH)

Kabacam, GokhanWedemeyer, HeinerHeidrich, BenjaminYalcin, KendalOnder, Fatih OguzDienes, Hans P.Manns, Michael P.2024-04-242024-04-2420120270-9139https://hdl.handle.net/11468/2308763rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) -- NOV 09-13, 2012 -- Boston, MA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Implications of HBsAg, HBcAg and HDAg Immunohistochemistry in Course and Treatment of Chronic Delta Hepatitis (CDH)Implications of HBsAg, HBcAg and HDAg Immunohistochemistry in Course and Treatment of Chronic Delta Hepatitis (CDH)Conference Object56392A393AWOS:000310955601407Q1